Pharmaceutical Packaging and Labelling Regulations Across Global Jurisdictions: A Comparative Review of Regulatory Requirements, Compliance Challenges and Future Perspectives

  • Unique Paper ID: 211207
  • Volume: 13
  • Issue: 6
  • PageNo: 3843-3865
  • Abstract:
  • Pharmaceutical packaging and labelling play a vital role in maintaining the quality, stability, safety, and proper use of medicinal products. Regulatory requirements for packaging materials and labelling vary across different countries and regulatory jurisdictions, although their primary objective is to protect the product and ensure patient safety. This review provides an overview of the regulatory requirements governing pharmaceutical packaging and labelling across major global jurisdictions, including the United States, European Union, India, United Kingdom, Japan, Canada, Australia, and international guidelines issued by the World Health Organization. The review discusses different types of pharmaceutical packaging, commonly used packaging materials, container-closure systems, mandatory labelling information, storage conditions, warning statements, package leaflets, serialization, and anti-counterfeiting measures. A comparative assessment of regulatory requirements is also presented to identify major similarities, differences, and challenges in global compliance. In addition, emerging trends such as digital labelling, smart packaging, track-and-trace technologies, patient-centric labelling, and sustainable packaging are discussed. Understanding these regulatory differences is essential for pharmaceutical manufacturers seeking global market access and regulatory compliance. Greater harmonization of packaging and labelling requirements may help reduce regulatory complexity, improve supply-chain efficiency, and enhance the safe and effective use of medicines worldwide.

Copyright & License

Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

BibTeX

@article{211207,
        author = {Chetan and Kapil},
        title = {Pharmaceutical Packaging and Labelling Regulations Across Global Jurisdictions: A Comparative Review of Regulatory Requirements, Compliance Challenges and Future Perspectives},
        journal = {International Journal of Innovative Research in Technology},
        year = {2026},
        volume = {13},
        number = {6},
        pages = {3843-3865},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=211207},
        abstract = {Pharmaceutical packaging and labelling play a vital role in maintaining the quality, stability, safety, and proper use of medicinal products. Regulatory requirements for packaging materials and labelling vary across different countries and regulatory jurisdictions, although their primary objective is to protect the product and ensure patient safety. This review provides an overview of the regulatory requirements governing pharmaceutical packaging and labelling across major global jurisdictions, including the United States, European Union, India, United Kingdom, Japan, Canada, Australia, and international guidelines issued by the World Health Organization. The review discusses different types of pharmaceutical packaging, commonly used packaging materials, container-closure systems, mandatory labelling information, storage conditions, warning statements, package leaflets, serialization, and anti-counterfeiting measures. A comparative assessment of regulatory requirements is also presented to identify major similarities, differences, and challenges in global compliance. In addition, emerging trends such as digital labelling, smart packaging, track-and-trace technologies, patient-centric labelling, and sustainable packaging are discussed. Understanding these regulatory differences is essential for pharmaceutical manufacturers seeking global market access and regulatory compliance. Greater harmonization of packaging and labelling requirements may help reduce regulatory complexity, improve supply-chain efficiency, and enhance the safe and effective use of medicines worldwide.},
        keywords = {Pharmaceutical packaging; Drug labelling; Regulatory requirements; Global regulations; Packaging materials; FDA; EMA; CDSCO; WHO; Patient safety.},
        month = {November},
        }

Cite This Article

Chetan, , & Kapil, (2026). Pharmaceutical Packaging and Labelling Regulations Across Global Jurisdictions: A Comparative Review of Regulatory Requirements, Compliance Challenges and Future Perspectives. International Journal of Innovative Research in Technology (IJIRT), 13(6), 3843–3865.

Related Articles